Sleep and breathing disorders
Oral presentation
Translational research in sleep apnoea: from the molecule and the signal to the clinic
Methods :
Pulmonary function testing, Cell and molecular biology, Physiology, General respiratory patient care
14:15
Sleep apnea syndrome and atherosclerosis: VE-Cadherin as a new antiatherogenic target?
O. Harki(LA TRONCHE, France)
COI
1
14:20
Proteomic profiling in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study.
A. Zapater Matute(Lleida, Spain)
COI
2
14:25
The effect of the GLP-1 analogue Liraglutide on intermittent hypoxia-induced systemic insulin resistance in vivo
A. King(Dublin 4, Ireland)
COI
3
14:30
Short-term continuous positive air pressure (CPAP) treatment: effects on cardiac structural changes and function in patients with obstructive sleep apnea (OSA)
L. Kondrataviciene(Kaunas, Lithuania)
COI
4
14:35
Long non-coding RNA FKSG29 over-expression in patients with obstructive sleep apnea modulates intermittent hypoxia-induced oxidative stress and cell apoptosis via sponging miR-23a-3p-IL6R signaling
Y. Chen(Kaohsiung, Taiwan)
COI
5
14:40
Polysomnographic characterization of the circadian blood pressure patterns in patients with obstructive sleep apnea
L. Pinilla(Adelaide, Australia)
COI
6
14:45
Autophagy impairment in patients with obstructive sleep apnea mediates intermittent hypoxia-induced apoptosis and cytotoxicity via hypermethylation of the MAP1LC3B and ATG5 promoter regions
Y. Chen(Kaohsiung, Taiwan)
COI
7
14:50
Intermittent hypoxia and pregnancy in a rat model: respiratory and metabolic effectson mothers and offspring
E. Valverde Pérez(Valladolid, Spain)
COI
8
14:55
DYSLIPIDEMIA PREVALENCE IN NON-OBESE NON-DIABETIC PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: DOES SEX MATTER?
M. Taşbakan(Izmir, Turkey)
COI
9
15:00
Late Breaking Abstract - Inflammasome activation: A keystone of proinflammatory response in obstructive sleep apnea
E. Díaz García(Madrid, Spain)
COI
10
15:05
Discussion
11
OA4393
. . .
